FXH Holdings — First Trust Health Care AlphaDEX Fund
All 78 reported holdings of First Trust Health Care AlphaDEX Fund (FXH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Organon & Company | 3.83% | $33.49M |
| Humana, Inc. | 2.95% | $25.80M |
| Elevance Health, Inc. | 2.78% | $24.33M |
| Molina Healthcare, Inc. | 2.53% | $22.10M |
| Cigna Group (the) | 2.36% | $20.61M |
| Globus Medical, Inc. | 2.27% | $19.81M |
| Exelixis, Inc. | 2.24% | $19.62M |
| Biogen, Inc. | 2.23% | $19.54M |
| Solventum Corp. | 2.23% | $19.52M |
| Incyte Corp. | 2.19% | $19.15M |
| Davita, Inc. | 2.19% | $19.10M |
| Bio-Rad Laboratories, Inc. | 2.18% | $19.02M |
| Universal Health Services, Inc. | 2.04% | $17.79M |
| Hca Healthcare, Inc. | 1.99% | $17.37M |
| Regeneron Pharmaceuticals, Inc. | 1.98% | $17.32M |
| Cardinal Health, Inc. | 1.98% | $17.27M |
| Zimmer Biomet Holdings, Inc. | 1.97% | $17.25M |
| Chemed Corp. | 1.95% | $17.03M |
| Encompass Health Corp. | 1.79% | $15.65M |
| Masimo Corp. | 1.74% | $15.19M |
| Ionis Pharmaceuticals, Inc. | 1.72% | $15.07M |
| Penumbra, Inc. | 1.72% | $15.05M |
| Amgen, Inc. | 1.70% | $14.90M |
| United Therapeutics Corp. | 1.67% | $14.59M |
| Pfizer, Inc. | 1.65% | $14.39M |
| Becton Dickinson & Company | 1.64% | $14.35M |
| Tenet Healthcare Corp. | 1.63% | $14.21M |
| Merck & Company, Inc. | 1.57% | $13.74M |
| Qiagen NV | 1.50% | $13.07M |
| Insmed, Inc. | 1.44% | $12.62M |
| Certara, Inc. | 1.40% | $12.21M |
| Natera, Inc. | 1.34% | $11.70M |
| Illumina, Inc. | 1.34% | $11.67M |
| Henry Schein, Inc. | 1.31% | $11.49M |
| Bristol-Myers Squibb Company | 1.30% | $11.34M |
| Quest Diagnostics, Inc. | 1.29% | $11.25M |
| Revvity, Inc. | 1.28% | $11.23M |
| Steris PLC | 1.27% | $11.14M |
| Labcorp Holdings, Inc. | 1.25% | $10.93M |
| Sarepta Therapeutics, Inc. | 1.25% | $10.89M |
| Resmed, Inc. | 1.24% | $10.81M |
| Gilead Sciences, Inc. | 1.22% | $10.66M |
| Medtronic PLC | 1.21% | $10.61M |
| Unitedhealth Group, Inc. | 1.19% | $10.36M |
| Cooper Companies, Inc. (the) | 1.14% | $9.99M |
| Ge Healthcare Technologies, Inc. | 1.11% | $9.70M |
| Waters Corp. | 0.90% | $7.86M |
| Align Technology, Inc. | 0.89% | $7.77M |
| Eli Lilly & Company | 0.88% | $7.69M |
| Agilent Technologies, Inc. | 0.88% | $7.67M |
| Neurocrine Biosciences, Inc. | 0.87% | $7.56M |
| Medline, Inc. | 0.87% | $7.56M |
| Halozyme Therapeutics, Inc. | 0.85% | $7.46M |
| Thermo Fisher Scientific, Inc. | 0.84% | $7.38M |
| Zoetis, Inc. | 0.84% | $7.36M |
| Biomarin Pharmaceutical, Inc. | 0.83% | $7.22M |
| Johnson & Johnson | 0.81% | $7.12M |
| Iqvia Holdings, Inc. | 0.80% | $7.03M |
| Abbott Laboratories | 0.77% | $6.69M |
| Medpace Holdings, Inc. | 0.75% | $6.60M |
| West Pharmaceutical Services, Inc. | 0.48% | $4.21M |
| Sotera Health Company | 0.44% | $3.85M |
| Royalty Pharma PLC | 0.42% | $3.70M |
| Edwards Lifesciences Corp. | 0.42% | $3.70M |
| Envista Holdings Corp. | 0.41% | $3.63M |
| Idexx Laboratories, Inc. | 0.41% | $3.54M |
| Intuitive Surgical, Inc. | 0.40% | $3.52M |
| Abbvie, Inc. | 0.39% | $3.45M |
| Stryker Corp. | 0.39% | $3.40M |
| Viking Therapeutics, Inc. | 0.39% | $3.40M |
| Vertex Pharmaceuticals, Inc. | 0.39% | $3.40M |
| Dexcom, Inc. | 0.38% | $3.36M |
| Danaher Corp. | 0.38% | $3.35M |
| Alnylam Pharmaceuticals, Inc. | 0.38% | $3.32M |
| Boston Scientific Corp. | 0.37% | $3.26M |
| Veeva Systems, Inc. | 0.36% | $3.15M |
| Morgan Stanley Institutional Liquidity Funds | 0.05% | $401.02K |
| Daiwa Capital Markets America Inc. | 0.00% | $13 |